Get the Stockscreener App
0.2452
0.45%
-0.0011
After Hours:
.25
0.0048
+1.96%
Azitra Inc stock is traded at $0.2452, with a volume of 461.51K.
It is down -0.45% in the last 24 hours and up +6.15% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.2463
Open:
$0.2414
24h Volume:
461.51K
Relative Volume:
0.04
Market Cap:
$3.97M
Revenue:
$7,500
Net Income/Loss:
$-10.96M
P/E Ratio:
-0.1069
EPS:
-2.2943
Net Cash Flow:
$-11.41M
1W Performance:
-1.92%
1M Performance:
+6.15%
6M Performance:
-43.86%
1Y Performance:
-15.39%
1-Day Range:
$0.24
$0.2583
1-Week Range:
$0.2301
$0.2685
52-Week Range:
$0.10
$1.40
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.2452 | 3.99M | 7,500 | -10.96M | -11.41M | -2.2943 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Azitra Inc Stock (AZTR) Latest News
Azitra receives U.S. patent for Netherton syndrome treatment - Investing.com
Azitra receives U.S. patent for Netherton syndrome treatment By Investing.com - Investing.com Australia
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program - Yahoo Finance
MSN Money - MSN
Azitra (AZTR) price target decreased by 50.00% to 1.38 - MSN
This nano-cap pharma stock surged 80% days after a listing warning — what’s fueling the rally? - MSN
Azitra's skin bacteria therapy cut water loss in pig skin tests - Stock Titan
Azitra (NYSE: AZTR) pursues reverse splits 1-for-2 to 1-for-30, 750M shares - Stock Titan
Azitra CEO-backed private placement priced up to $10.5M, potential $20.9M; stock jumps 90% - MSN
AZTR (Azitra Inc) Q3 2025 EPS outpaces analyst estimates, shares edge higher on positive earnings surprise.Asset Turnover - Cổng thông tin điện tử tỉnh Lào Cai
Azitra (AZTR) CFO awarded 35,524 stock options at $0.2127 - Stock Titan
Azitra (AZTR) CEO Francisco Salva receives stock options for 220,879 shares - Stock Titan
Azitra (AZTR) awards COO 64,300 stock options at $0.2127 - Stock Titan
Azitra (AZTR) Stock: Consolidation or Breakout (Smart Money Outflows) 2026-04-18Breakout Watch - Cổng thông tin điện tử tỉnh Lào Cai
Is Azitra (AZTR) Stock Good for Active Traders | Price at $0.22, Down 4.23%Trader Community Insights - Newser
Aug Mood: Can Azitra Inc navigate macro headwinds2026 Market Overview & Verified Momentum Stock Alerts - baoquankhu1.vn
Why are shares of Azitra rising? - MSN
Bear Alert: Is Azitra Inc impacted by rising ratesEarnings Miss & AI Optimized Trade Strategies - baoquankhu1.vn
AZTR Stock Price, Quote & Chart | AZITRA INC (NYSEARCA:AZTR) - ChartMill
Is Azitra (AZTR) Stock Safe to Buy Now | Price at $0.21, Down 5.90%Social Trading - UBND thành phố Hải Phòng
Azitra Inc. (AZTR) surges over 44% after hours—here's why it's trending - MSN
Azitra Secures PIPE Financing to Advance Cosmetic Programs - The Globe and Mail
Azitra Secures $31.4M Private Placement to Launch Innovative Protein and Peptide Programs for Cosmetic and Cosmeceutical Markets - Minichart
Azitra | 8-K: Current report - Moomoo
Azitra Raises $10.5M in PIPE, Up to $31.4M With Warrants; Signs Registration Rights Deal - TradingView
Azitra (NYSE: AZTR) secures up to $31.4M in PIPE with warrants - Stock Titan
If You Invested $1,000 in Azitra Inc (AZTR) - Stock Titan
Why Are Shares Of Azitra Rising? - Sahm
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings - Sahm
Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Sahm
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Cap:
|
Volume (24h):